This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Mar;19(3):149-150.

doi: 10.1038/d41573-020-00016-0.

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li, Erik De Clercq

PMID: 32127666
DOI: 10.1038/d41573-020-00016-0

Therapeutic options for the 2019 novel coronavirus (2019-nCoV)

Guangdi Li et al. Nat Rev Drug Discov. 2020 Mar.

. 2020 Mar;19(3):149-150.

doi: 10.1038/d41573-020-00016-0.

Authors

Guangdi Li, Erik De Clercq

PMID: 32127666
DOI: 10.1038/d41573-020-00016-0

No abstract available

PubMed Disclaimer

Similar articles

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Wang M, et al. Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4. Cell Res. 2020. PMID: 32020029 Free PMC article. No abstract available.
Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA. Martinez MA. Antimicrob Agents Chemother. 2020 Apr 21;64(5):e00399-20. doi: 10.1128/AAC.00399-20. Print 2020 Apr 21. Antimicrob Agents Chemother. 2020. PMID: 32152082 Free PMC article. Review.
Rapid review for the anti-coronavirus effect of remdesivir.
Li Z, Wang X, Cao D, Sun R, Li C, Li G. Li Z, et al. Drug Discov Ther. 2020;14(2):73-76. doi: 10.5582/ddt.2020.01015. Drug Discov Ther. 2020. PMID: 32378648 Review.
Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ, Suárez I, Priesner V, Fätkenheuer G, Rybniker J. Malin JJ, et al. Clin Microbiol Rev. 2020 Oct 14;34(1):e00162-20. doi: 10.1128/CMR.00162-20. Print 2020 Dec 16. Clin Microbiol Rev. 2020. PMID: 33055231 Free PMC article. Review.
Novel 2019 coronavirus: Genome structure, clinical trials, and outstanding questions.
Jogalekar MP, Veerabathini A, Gangadaran P. Jogalekar MP, et al. Exp Biol Med (Maywood). 2020 Jun;245(11):964-969. doi: 10.1177/1535370220920540. Epub 2020 Apr 19. Exp Biol Med (Maywood). 2020. PMID: 32306751 Free PMC article. Review.

See all similar articles

Cited by

Synthesis of Natural and Sugar-Modified Nucleosides Using the Iodine/Triethylsilane System as N-Glycosidation Promoter.
Cimafonte M, Esposito A, De Fenza M, Zaccaria F, D'Alonzo D, Guaragna A. Cimafonte M, et al. Int J Mol Sci. 2024 Aug 20;25(16):9030. doi: 10.3390/ijms25169030. Int J Mol Sci. 2024. PMID: 39201716 Free PMC article.
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (M^pro).
Yang Y, Luo YD, Zhang CB, Xiang Y, Bai XY, Zhang D, Fu ZY, Hao RB, Liu XL. Yang Y, et al. ACS Omega. 2024 Aug 2;9(32):34196-34219. doi: 10.1021/acsomega.4c03023. eCollection 2024 Aug 13. ACS Omega. 2024. PMID: 39157135 Free PMC article. Review.
Radiosynthesis of [¹⁸F]brequinar for in vivo PET imaging of hDHODH for potential studies of acute myeloid leukemia and cancers.
Banka VK, Sainas S, Martino E, Wang J, Lolli ML, Ding YS. Banka VK, et al. RSC Med Chem. 2024 Jul 22;15(9):3147-61. doi: 10.1039/d4md00433g. Online ahead of print. RSC Med Chem. 2024. PMID: 39149561
Study of different heterocycles showing significant anti-severe acute respiratory syndrome 2 activity in vitro and in vivo.
Yengoyan A, Gomktsyan T, Pivazyan V, Ghazaryan E, Shainova R, Karapetyan A, Avetyan D, Aslanyan L, Baroyan K, Tuzikov A, Sargsyan M, Baghdasaryan B, Bayramyan N, Hakobyan S, Poghosyan A, Avetisyan A, Avagyan H, Hakobyan L, Zaven K. Yengoyan A, et al. Vet World. 2024 Jun;17(6):1281-1290. doi: 10.14202/vetworld.2024.1281-1290. Epub 2024 Jun 14. Vet World. 2024. PMID: 39077461 Free PMC article.
Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.
Mia ME, Howlader M, Akter F, Hossain MM. Mia ME, et al. Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec. Clin Pathol. 2024. PMID: 39070952 Free PMC article. Review.

See all "Cited by" articles

References

1. De Clercq, E. & Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 29, 695–747 (2016). - PubMed - DOI - PMC
1. Zumla, A., Chan, J. F., Azhar, E. I., Hui, D. S. & Yuen, K. Y. Coronaviruses — drug discovery and therapeutic options. Nat. Rev. Drug Discov. 15, 327–347 (2016). - PubMed - DOI - PMC
1. Morse, J. S., Lalonde, T., Shiqing, X. & Liu, W. R. Learning from the past: possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019‐nCoV. ChemBioChem https://doi.org/10.1002/cbic.202000047 (2020). - DOI
1. De Clercq, E. New nucleoside analogues for the treatment of hemorrhagic fever virus infections. Chem. Asian J. 14, 3962–3968 (2019). - PubMed - DOI - PMC
1. Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. https://doi.org/10.1038/s41422-020-0282-0 (2020). - DOI

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations